Key result
High renal microvascular pulsatility at discharge linked to ~3.4-fold higher post-AHF death or rehospitalization.
Why the study?
In acute heart failure, distinguishing renal congestion from low perfusion using routine bedside assessment remains difficult. The prognostic value of quantifying cyclic renal microvascular variation at discharge using superb microvascular imaging (SMI) had not been established.
Does renal microvascular pulsatility quantified by superb microvascular imaging (pulsus VI >0.145) at discharge predict the composite of all-cause death or heart-failure rehospitalisation in patients hospitalised for acute heart failure?
Cohort (n=140)
Does renal microvascular pulsatility quantified by superb microvascular imaging (pulsus VI >0.145) at discharge predict the composite of all-cause death or heart-failure rehospitalisation in patients hospitalised for acute heart failure?
Renal microvascular pulsatility quantified by superb microvascular imaging at discharge independently predicts post-discharge mortality and heart failure rehospitalization in acute heart failure patients, offering a novel non-invasive risk stratification tool.
Answers are grounded in this paper and cite their sources.
Should not yet change discharge risk assessment in acute heart failure; hypothesis-generating and requires prospective validation.
Background Renal dysfunction in acute heart failure is associated with poor prognosis. Although renal congestion has gained attention, it remains difficult to distinguish congestion from low perfusion using routine bedside assessment. Superb microvascular imaging (SMI) uses clutter suppression to attenuate motion artefacts, enabling contrast-free visualisation of low-velocity renal microvascular flow and quantification using the vascular index (VI). Purpose To investigate the prognostic value of an SMI-derived index of cyclic microvascular variation at discharge for clinical outcomes. Methods We prospectively enrolled 140 consecutive patients hospitalised as an emergency for acute heart failure between 2023 and 2025 who were discharged alive (age 80±11 years; 60% male). At discharge, blood and urine biochemistry, transthoracic echocardiography, renal venous Doppler, and renal ultrasound with SMI were performed. VI was defined as the percentage of flow-signal area within predefined regions of interest in both the renal cortex and medulla (Figure1A). Pulsus VI was defined as the difference between maximum and minimum VI within a cardiac cycle, averaged over three cardiac cycles (Figure1B). The primary endpoint was a composite of all-cause death or heart-failure rehospitalisation. Discrimination was assessed by ROC analysis, and time-to-event analyses by Kaplan–Meier and Cox models. Results Over 377±272 days of follow-up, 23 patients experienced the primary endpoint. Patients with events had lower use of sodium–glucose cotransporter-2 inhibitors and lower haemoglobin and eGFR, and higher urinary beta2-microglobulin, liver-type fatty acid-binding protein, and albumin-to-creatinine ratio. No significant differences were observed in echocardiographic parameters or renal venous Doppler patterns. Pulsus VI was significantly higher in patients with events. Pulsus VI predicted the primary endpoint (AUC 0.662). Patients with pulsus VI above a ROC-derived cut-off (>0.145) had higher event risk (log-rank p<0.01; unadjusted HR 3.4, 95% CI 1.40-8.30) (Figure2). In multivariable Cox models, pulsus VI above cut-off remained associated with the endpoint after adjustment for haemoglobin, eGFR and BNP (model 1: adjusted HR 2.8, 95% CI 1.08-7.09, p=0.03) and after adjustment for urinary liver-type fatty acid-binding protein, albumin-to-creatinine ratio and beta2-microglobulin (model 2: adjusted HR 3.4, 95% CI 1.27-9.26, p=0.01). Conclusion Renal microvascular pulsatility quantified by SMI at discharge was associated with post-discharge outcomes in acute heart failure, supporting its potential role as a non-invasive tool for risk stratification beyond conventional renal function measures.
No takes yet. Share an insight, caveat, or question.
Kayama et al. (2026) conducted a cohort in Acute heart failure (n=140). Renal microvascular pulsatility by superb microvascular imaging (pulsus VI >0.145) vs. Pulsus VI <=0.145 was evaluated on Composite of all-cause death or heart-failure rehospitalisation (HR 3.4, 95% CI 1.40-8.30, p=<0.01). High renal microvascular pulsatility (pulsus VI >0.145) at discharge predicted all-cause death or heart-failure rehospitalisation in acute heart failure (HR 3.4; 95% CI 1.40-8.30; p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: